Aktis Oncology, Inc. Retained Earnings
Aktis Oncology, Inc. (AKTS) had Retained Earnings of -$199.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$199.03M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$174.89M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$156.56M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$199.03M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$174.89M 10-Q · filed 2026-05-11 |
| 2025-12-31 | -$156.56M 10-Q · filed 2026-08-13 |